Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

AstraZeneca image

AZ and Mitsubishi partner on diabetic nephropathy

August 20, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy

AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …

News
Brilinta image

Reprieve for AstraZeneca as US drops drug investigation

August 19, 2014
Sales and Marketing AstraZeneca, Brilinta, US, blood, justice, plato

The US Justice Department has pulled a controversial investigation into AstraZeneca’s pivotal clinical trial after finding no wrongdoing. The inquiry …

News
Shire logo

AbbVie/Shire deal under threat from tax laws

August 7, 2014
Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, Shire, tax inversion

The £32 billion deal between AbbVie and Irish specialist biotech Shire could be under threat from new rules in the …

News
astrazeneca-headquarters_low_res

AstraZeneca’s second quarter beats estimates

July 31, 2014
Research and Development, Sales and Marketing AstraZeneca, Nexium, Pfizer

AstraZeneca posted a set of healthy financial results today as key platforms performed well for the company. Revenue in the …

News

AstraZeneca secures respiratory drugs from Almirall

July 30, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs

AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …

News

More action needed on antibiotic resistance

July 25, 2014
Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh

Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …

News
Medimmune image

MedImmune to work with biotech Advaxis on cancer

July 22, 2014
Research and Development, Sales and Marketing Advaxis, AstraZeneca, Cancer, MEDI4736, MedImmune, oncology, pd1

AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …

News

Pharma firms give researchers access

July 22, 2014
Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline, Janssen R&D, MRC, Pfizer, Takeda, UCB, lilly, research, virtual library

 UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …

News
Astrazeneca's Cambridge Biomedical Campus image

AstraZeneca reveals Cambridge plans

July 21, 2014
Research and Development, Sales and Marketing AstraZeneca, Cambridge, cbc, research, silicon fen

AstraZeneca’s new international HQ on the Cambridge Biomedical Campus (CBC), due to open in two years’ time, will feature an …

News
astrazeneca image

FDA rejects olaparib

June 27, 2014
Sales and Marketing AstraZeneca, Cancer, FDA, PARP, adp, olaparib

AstraZeneca has been dealt a blow by a key advisory committee to the US Food and Drug Administration, which has …

News
Astrazeneca image

AstraZeneca faces olaparib questions

June 24, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, FDA, olaparib, ovarian

AstraZeneca is facing questions from US regulators over the efficacy of one of its most promising late-stage treatments. Olaparib is …

News
AbbVie logo

AbbVie moves in on Shire with $46 billion bid

June 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger

AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …

News

Genome-driven lung cancer trial launches

June 18, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Genentech, MedImmune, Pfizer, genome, lung cancer

Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …

News
Astrazeneca image

AstraZeneca signs $240m asthma deal with UK biotech

June 12, 2014
Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen

UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …

News
Medicity image

MediCity hub moves forward

June 11, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BioCity, alderley park, johnson, medcity, medicity

 Nine new businesses have signed tenancy agreements at Nottingham’s MediCity, bringing to 20 the number of companies which have been …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025